Legislation requiring insurance coverage of biomarkers has passed in a number of states, and is pending in others.
See an October 17, 2023, webinar (11 PT 2 ET) sponsored by Concert Genetics on the status of state biomarker laws. They've lined up an impressive group of guest speakers.
Find out more here:
Partial text:
A wave of legislation has passed in statehouses across the country requiring insurance coverage of biomarker testing. These bills have wide-ranging implications that are unfolding in real-time as they are enacted into law. They offer both the promise of expanded access to clinically valuable testing for patients as well as challenges and uncertainties related to implementation, compliance, and their ultimate impact on patient care.
In this webinar, panelists from Tempus, Foley Hoag, Blue Cross Blue Shield Association (BCBSA), and Blue Cross and Blue Shield of Louisiana (BCBSLA) will discuss efforts to provide patients with affordable, evidence-based, clinically appropriate testing in the context of this emerging legislation.
